DD146459A5 - Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate - Google Patents

Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate Download PDF

Info

Publication number
DD146459A5
DD146459A5 DD79216114A DD21611479A DD146459A5 DD 146459 A5 DD146459 A5 DD 146459A5 DD 79216114 A DD79216114 A DD 79216114A DD 21611479 A DD21611479 A DD 21611479A DD 146459 A5 DD146459 A5 DD 146459A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
dimethoxy
pyrrolidinylmethyl
acid
compound
Prior art date
Application number
DD79216114A
Other languages
German (de)
English (en)
Inventor
Michel Thominet
Jaques Perrot
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DD146459A5 publication Critical patent/DD146459A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD79216114A 1978-10-11 1979-10-09 Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate DD146459A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7829005A FR2438650A1 (fr) 1978-10-11 1978-10-11 N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire

Publications (1)

Publication Number Publication Date
DD146459A5 true DD146459A5 (de) 1981-02-11

Family

ID=9213607

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79216114A DD146459A5 (de) 1978-10-11 1979-10-09 Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate

Country Status (44)

Country Link
US (1) US4364867A (da)
JP (1) JPS5553268A (da)
AR (1) AR223186A1 (da)
AT (1) AT376203B (da)
AU (1) AU528827B2 (da)
BE (1) BE879139A (da)
BG (1) BG30926A3 (da)
CA (1) CA1133913A (da)
CH (1) CH641775A5 (da)
CS (1) CS221527B2 (da)
CY (1) CY1203A (da)
DD (1) DD146459A5 (da)
DE (1) DE2939914C2 (da)
DK (1) DK146157C (da)
EG (1) EG14181A (da)
ES (1) ES8102093A1 (da)
FI (1) FI68220C (da)
FR (1) FR2438650A1 (da)
GB (1) GB2033900B (da)
GR (1) GR65219B (da)
HK (1) HK12384A (da)
HU (1) HU178113B (da)
IE (1) IE48957B1 (da)
IL (1) IL58379A (da)
IN (1) IN151482B (da)
IT (1) IT1162680B (da)
JO (1) JO1041B1 (da)
LU (1) LU81745A1 (da)
MA (1) MA18603A1 (da)
MC (1) MC1288A1 (da)
MX (1) MX6194E (da)
NL (1) NL7907307A (da)
NO (1) NO152971C (da)
NZ (1) NZ191699A (da)
OA (1) OA06351A (da)
PH (1) PH15431A (da)
PL (1) PL125527B1 (da)
PT (1) PT70277A (da)
RO (1) RO78157A (da)
SE (1) SE434835B (da)
SU (1) SU946401A3 (da)
YU (1) YU43460B (da)
ZA (1) ZA795375B (da)
ZM (1) ZM8179A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US6197309B1 (en) 1998-08-03 2001-03-06 Ronald E. Wheeler Prostate formula

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (da) * 1966-01-21 1968-05-06
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
CH605793A5 (da) * 1974-03-05 1978-10-13 Ile De France
US4158060A (en) * 1974-12-18 1979-06-12 Synthelabo 2-Methoxy-benzamide derivatives
FR2358892A1 (fr) * 1976-07-19 1978-02-17 Ile De France N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Also Published As

Publication number Publication date
MA18603A1 (fr) 1980-07-01
DK146157B (da) 1983-07-11
SU946401A3 (ru) 1982-07-23
AT376203B (de) 1984-10-25
CY1203A (en) 1983-12-31
YU232279A (en) 1983-02-28
IE791903L (en) 1980-04-11
GR65219B (en) 1980-07-30
SE434835B (sv) 1984-08-20
OA06351A (fr) 1981-06-30
SE7908227L (sv) 1980-04-12
AU5151979A (en) 1980-04-17
PL125527B1 (en) 1983-05-31
NL7907307A (nl) 1980-04-15
AR223186A1 (es) 1981-07-31
NO152971C (no) 1985-12-27
DE2939914A1 (de) 1980-04-30
FI68220C (fi) 1985-08-12
IL58379A0 (en) 1980-01-31
ZA795375B (en) 1980-10-29
BG30926A3 (en) 1981-09-15
NO793240L (no) 1980-04-14
NO152971B (no) 1985-09-16
EG14181A (en) 1984-09-30
LU81745A1 (fr) 1980-05-07
FR2438650A1 (fr) 1980-05-09
AU528827B2 (en) 1983-05-12
CH641775A5 (fr) 1984-03-15
CS221527B2 (en) 1983-04-29
PT70277A (fr) 1979-11-01
MX6194E (es) 1984-12-13
FR2438650B1 (da) 1981-08-14
IT7950444A0 (it) 1979-10-03
DK146157C (da) 1983-12-05
JPS641470B2 (da) 1989-01-11
CA1133913A (en) 1982-10-19
FI68220B (fi) 1985-04-30
ES484814A0 (es) 1980-12-16
IT1162680B (it) 1987-04-01
DK422879A (da) 1980-04-12
BE879139A (fr) 1980-04-02
FI793041A (fi) 1980-04-12
ZM8179A1 (en) 1980-07-21
ATA639179A (de) 1984-03-15
PH15431A (en) 1983-01-18
HK12384A (en) 1984-02-24
JO1041B1 (en) 1982-07-10
US4364867A (en) 1982-12-21
MC1288A1 (fr) 1980-07-22
ES8102093A1 (es) 1980-12-16
IE48957B1 (en) 1985-06-26
GB2033900B (en) 1982-09-15
IL58379A (en) 1983-03-31
IN151482B (da) 1983-04-30
RO78157A (ro) 1982-02-01
GB2033900A (en) 1980-05-29
JPS5553268A (en) 1980-04-18
PL218673A1 (da) 1980-07-28
DE2939914C2 (de) 1986-05-22
HU178113B (en) 1982-03-28
YU43460B (en) 1989-08-31
NZ191699A (en) 1981-11-19

Similar Documents

Publication Publication Date Title
DE2904445C2 (de) N↓1↓-(4-Amino-6.7-dimethoxy-2-chinazolyl)-N↓1↓-methyl-N↓2↓-(2-tetrahydrofuroyl)-1.3-propandiamin, seine Herstellung und seine pharmazeutische Verwendung
DE2106418C2 (de) N-substituierte 2-Pyrrolidon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0136470B1 (de) Injizierbare Lösung zur Behandlung von Entzündungen
EP0276803B1 (de) 1-(4-Hydroxy-3,5-di-tert.-butyl-benzoyl)-homopiperazin, verschiedene von dessen Derivaten, Verfahren zur Herstellung dieser Verbindungen, die sie enthaltenden Arzneimittel und ihre Verwendung
DE2708236A1 (de) 3-aryl-2-oxazolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3129759A1 (de) Muramylpeptide enthaltende arzneimittel und ihre verwendung
DE2635209C2 (de) 4-(2-Benzoyloxy-3-tert.butylamino-propoxy)-2-methylindol, dessen (S)-Enantiomeres, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Heilmittel
DD146459A5 (de) Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate
DE2463023C2 (de) S-Triazolo-[5,1-a]-isochinolinderivate, deren Salze und Verfahren zu deren Herstellung
CH647677A5 (de) 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung.
CH628335A5 (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines which act as potentiators for sulphonamides
DE2344611A1 (de) 5-(substituierte phenoxy)-4-aminound -substituierte aminopyrimidine
DE2711149C3 (de) N-Substituierte[4-Chlor-6-(23-xylidino)-2· pyrimidinyl- thio] essigsäureamide sowie Verfahren zu deren Herstellung
DE3045720A1 (de) N-pyrimidinyl-carbaminsaeureester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2831671A1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
DE2508251C2 (de) Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2414345C3 (de) (Z)-(3-Methyl-4-oxo-5-piperidinothiazolidin-2-yIiden)-esssigsäure und Verfahren zur Herstellung von Thiazolidinessigsäure-Derivaten
DE2901629A1 (de) 4-pyrimidylsulfide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und verwendung
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE2450161A1 (de) Glutamylamidderivate von dopamin
DE2511852A1 (de) Neue breitspektrum-antibiotika
AT358009B (de) Verfahren zur herstellung von neuen 2-(4- hydroxy-3-(alkylthio-, alkylsulfinyl- oder alkylsulfonyl) phenyl)-aethylaminen, deren estern und salzen
DE2025341C3 (de) 2,4,6-Trimethoxybenzoesäure-2-morpholinoäthyl-ester und seine Säureadditionssalze, Verfahren zu deren Herstellung und deren Verwendung als Wirkstoff in pharmazeutischen Zubereitungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee